Name: | Description: | Size: | Format: | |
---|---|---|---|---|
3.2 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Aggressive natural killer cell leukemia (ANKL) is extremely rare and habitually manifests as a systemic disease with multiorgan failure that rapidly evolves to death. The neoplastic natural killer (NK) cells usually harbor the Epstein-Barr virus (EBV) with a latent viral infection pattern type II; they often have a cytoplasmic CD3ε+ and surface CD3-, CD2+, and CD56+ immunophenotype, and they show complex genetic abnormalities affecting multiple tumor suppressor genes and oncogenes. We present a rare case of CD56-negative ANKL and review the clinical and laboratorial criteria for the diagnosis, as well as the available therapies.
Description
Keywords
Pedagogical Context
Citation
Case Reports in Hematology, vol. 2017, Article ID 3724017, 9 pages, 2017. https://doi.org/10.1155/2017/3724017
Publisher
Hindawi Publishing Corporation